Literature DB >> 19966199

Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.

Deborah van der Stoep, Gert-Jan Braunstahl, Jende van Zeben, Jacques Wouters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19966199     DOI： 10.3899/jrheum.090307

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  11 in total

1.  Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab.

Authors:  Peter Korsten; Nadera J Sweiss; Ulf Nagorsnik; Timothy B Niewold; Hermann-Josef Gröne; Oliver Gross; Gerhard A Müller
Journal:  Am J Kidney Dis       Date:  2010-10-25       Impact factor: 8.860

2.  Adalimumab induced pulmonary sarcoid reaction.

Authors:  S Bhargava; D M Perlman; T L Allen; J H Ritter; M Bhargava
Journal:  Respir Med Case Rep       Date:  2013-10-26

Review 3.  Advances in the diagnosis and treatment of sarcoidosis.

Authors:  Marc A Judson
Journal:  F1000Prime Rep       Date:  2014-10-01

4.  Pulmonary Sarcoidosis That Developed During the Treatment of a Patient With Crohn Disease by Using Infliximab.

Authors:  Tae Kyun Kim; Sun Hyung Kang; Hee Seok Moon; Jae Kyu Sung; Hyun Yong Jeong; Hyuk Soo Eun
Journal:  Ann Coloproctol       Date:  2017-04-28

Review 5.  Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review.

Authors:  Chaohe Zhang; Jiyao Sheng; Guangquan Li; Lihong Zhao; Yicun Wang; Wei Yang; Xiaoxiao Yao; Lihuan Sun; Zhuo Zhang; Ranji Cui
Journal:  Front Pharmacol       Date:  2020-01-15       Impact factor: 5.810

Review 6.  Current and emerging pharmacological treatments for sarcoidosis: a review.

Authors:  Scott H Beegle; Kerry Barba; Romel Gobunsuy; Marc A Judson
Journal:  Drug Des Devel Ther       Date:  2013-04-12       Impact factor: 4.162

Review 7.  Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.

Authors:  Daniel Sánchez-Cano; José Luis Callejas-Rubio; Ricardo Ruiz-Villaverde; Raquel Ríos-Fernández; Norberto Ortego-Centeno
Journal:  Mediators Inflamm       Date:  2013-08-01       Impact factor: 4.711

8.  Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis.

Authors:  Cécile-Audrey Durel; Elodie Feurer; Jean-Baptiste Pialat; Emilie Berthoux; Roland D Chapurlat; Cyrille B Confavreux
Journal:  BMC Neurol       Date:  2013-12-28       Impact factor: 2.474

9.  Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review.

Authors:  Jae Kyeom Sim; Sung Yong Lee; Jae Jeong Shim; Kyung Ho Kang
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

10.  Granulomatous interstitial nephritis secondary to adalimumab therapy.

Authors:  Vicki Sandys; Brona Moloney; Louise Lane; Junaid Qazi; Brendan Doyle; Maurice Barry; Sean Leavey; Peter Conlon
Journal:  Clin Kidney J       Date:  2017-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.